CRL Rapid Response™ is a saliva-based molecular test, which is authorized by the FDA under an Emergency Use Authorization (EUA), that can be self-collected and shipped to our lab when determined to be appropriate by a healthcare provider. Results of the test can confirm if the virus is detected in the saliva of an individual. Since no nasal swab is required, collection is minimally invasive and can be self-administered without the assistance of a healthcare worker.